Neural circuits and mechanisms underlying maladaptive risk-taking following cocaine self-administration
可卡因自我给药后适应不良冒险的神经回路和机制
基本信息
- 批准号:10004014
- 负责人:
- 金额:$ 24.9万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2019
- 资助国家:美国
- 起止时间:2019-09-01 至 2022-08-31
- 项目状态:已结题
- 来源:
- 关键词:AbstinenceAddressAffectAgonistAmygdaloid structureAttenuatedBehaviorBehavioralBrainCharacteristicsChronicCocaineCocaine DependenceCocaine UsersCommunicationCoupledCuesDataDecision MakingDevelopmentDiseaseDopamine D2 ReceptorDrug AddictionDrug usageElectrophysiology (science)ExhibitsFemaleFoundationsFunctional disorderGoalsHumanHypersensitivityImpairmentInsula of ReilKnowledgeLaboratoriesLearningLifeMediatingMental disordersModelingMonitorNeurobiologyNeuronsNucleus AccumbensPathway interactionsPharmaceutical PreparationsPhasePlayPositioning AttributeProbabilityProcessPunishmentRattusRecording of previous eventsRelapseResearchRewardsRiskRisk-TakingRodentRoleSelf AdministrationSex DifferencesStructureTestingTimeTrainingaddictioncocaine usecostdrug of abuseexperimental studyin vivoinformation processinginsightmaleneural circuitneuromechanismnovelnovel therapeuticsoptogeneticspre-clinical researchpreventprogramsreal time monitoringreceptor functionrelating to nervous systemsexsubstance abusertargeted treatmenttime use
项目摘要
Project Summary: Drug addiction is associated with poor decision-making and elevated risk-taking, which can
persist well into abstinence and contribute to relapse. These adverse behavioral changes are particularly
evident in cocaine users, who exhibit pronounced elevations in risk-taking both in the laboratory and in real
world settings. The majority of preclinical research to date has focused on the mechanisms by which
hypersensitivity to reward promotes poor decision-making and continued drug use; however, we have only a
rudimentary understanding of the brain circuits that encode the risk of punishment associated with these
maladaptive choices. The long term goal of this project is to elucidate the neurobiology of drug-induced
maladaptive decision-making involving punishment and, thereby, identify neural targets for therapeutically
attenuating risk-taking in substance abusers. Relevant to this goal, our laboratory has established a rat model
of risk-taking (the “Risky Decision-Making Task”; RDT) that recapitulates real-life decision-making in that it
incorporates both reward and risk of punishment. Using this model, our lab showed that chronic cocaine self-
administration causes lasting increases in punished risk-taking behavior and that dopamine D2 receptor (D2R)
function in the nucleus accumbens (NAc) plays a critical role in this behavior. Further, preliminary data reveal
unique roles in punishment-related decision-making for the basolateral amygdala (BLA) and insular cortex
(INS), both of which project to the NAc and are impacted by drugs of abuse. The proposed experiments will
build on these findings and test the central hypothesis that cocaine-induced insensitivity to risk of punishment
is mediated both by attenuated D2R function in the NAc and by disrupted communication between the NAc
and afferent structures that convey essential information regarding anticipation and probability of punishment.
This hypothesis will be tested using a combination of in vivo electrophysiology and optogenetics to allow both
in vivo manipulation and real-time monitoring of neural activity during decision-making behavior. Aim 1 will
determine whether alterations in NAc D2R function mediate cocaine-induced insensitivity to risk of punishment
by first testing whether a D2R agonist restores altered neural activity in the NAc during decision-making in rats
with a history of cocaine self-administration. In a second experiment, D2R-expressing neurons in the NAc will
be optogenetically manipulated during decision-making to test whether inhibition of these neurons reverses
cocaine-induced increases in risk-taking. Aim 2 will determine whether dysfunction in the BLA and INS
afferents to the NAc contributes to cocaine-induced insensitivity to risk of punishment. These experiments will
determine how activation or silencing of these circuits affects risk-taking and neural encoding of risk of
punishment following cocaine self-administration. Collectively, these findings will provide insight into how the
neural circuitry underlying risk-taking may become compromised by drugs of abuse and, thus, reveal brain
targets that could be modulated to reduce maladaptive risk-taking associated with drug addiction.
项目摘要:吸毒成瘾与决策失误和冒险行为增加有关,这可能会导致
这些不良行为改变尤其容易导致戒毒。
这在可卡因使用者中很明显,他们在实验室和现实中的冒险行为都表现出明显的升高
迄今为止,大多数临床前研究都集中在其机制上。
对奖励的过度敏感会导致糟糕的决策和持续的吸毒;然而,我们只有一个
对编码与这些相关的惩罚风险的大脑回路有初步的了解
该项目的长期目标是阐明药物诱导的神经生物学。
涉及惩罚的适应不良决策,从而确定治疗的神经目标
与此目标相关,我们的实验室建立了大鼠模型。
风险承担(“风险决策任务”;RDT),概括了现实生活中的决策
我们的实验室利用这个模型,结合了奖励和惩罚风险,证明了慢性可卡因会自我影响。
给药会导致受惩罚的冒险行为持续增加,并且多巴胺 D2 受体 (D2R)
此外,初步数据显示,伏隔核(NAc)的功能在这种行为中发挥着关键作用。
基底外侧杏仁核 (BLA) 和岛叶皮层在惩罚相关决策中的独特作用
(INS),两者都投射到 NAc 并受到滥用药物的影响。拟议的实验将。
以这些发现为基础,检验可卡因导致对惩罚风险不敏感的中心假设
由 NAc 中 D2R 功能减弱和 NAc 之间通讯中断介导
以及传递有关预期和惩罚概率的基本信息的传入结构。
该假设将通过体内电生理学和光遗传学的结合进行测试,以允许
目标 1 将在体内操纵和实时监测决策行为期间的神经活动。
确定 NAc D2R 功能的改变是否介导可卡因引起的对惩罚风险的不敏感
首先测试 D2R 激动剂是否可以恢复大鼠决策过程中 NAc 中改变的神经活动
在第二个实验中,NAc 中表达 D2R 的神经元将具有自我施用可卡因的历史。
在决策过程中进行光遗传学操作,以测试这些神经元的抑制是否逆转
可卡因引起的冒险行为增加将决定 BLA 和 INS 是否出现功能障碍。
NAc 的传入有助于可卡因引起的对惩罚风险的不敏感。
确定这些回路的激活或沉默如何影响风险承担和风险的神经编码
总的来说,这些发现将有助于了解可卡因自我给药后的惩罚。
冒险行为背后的神经回路可能会受到滥用药物的损害,从而揭示大脑
可以调节目标以减少与毒瘾相关的适应不良的冒险行为。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Caitlin Anne Orsini其他文献
Caitlin Anne Orsini的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Caitlin Anne Orsini', 18)}}的其他基金
Investigation of the neurobiological mechanisms underlying estradiol-mediated risk aversion in females
女性雌二醇介导的风险厌恶的神经生物学机制的研究
- 批准号:
10587322 - 财政年份:2023
- 资助金额:
$ 24.9万 - 项目类别:
Examination of fentanyl-induced insensitivity to risk of punishment during decision making and the potential use of methadone and buprenorphine in attenuating risk-taking deficits
检查决策过程中芬太尼引起的对惩罚风险的不敏感性以及美沙酮和丁丙诺啡在减轻风险承担缺陷方面的潜在用途
- 批准号:
10373348 - 财政年份:2022
- 资助金额:
$ 24.9万 - 项目类别:
Examination of fentanyl-induced insensitivity to risk of punishment during decision making and the potential use of methadone and buprenorphine in attenuating risk-taking deficits
检查决策过程中芬太尼引起的对惩罚风险的不敏感性以及美沙酮和丁丙诺啡在减轻风险承担缺陷方面的潜在用途
- 批准号:
10580692 - 财政年份:2022
- 资助金额:
$ 24.9万 - 项目类别:
Neural circuits and mechanisms underlying maladaptive risk-taking following cocaine self-administration
可卡因自我给药后适应不良冒险的神经回路和机制
- 批准号:
9986142 - 财政年份:2019
- 资助金额:
$ 24.9万 - 项目类别:
Neural circuits and mechanisms underlying maladaptive risk-taking following cocaine self-administration
可卡因自我给药后适应不良冒险的神经回路和机制
- 批准号:
10249237 - 财政年份:2019
- 资助金额:
$ 24.9万 - 项目类别:
Interactions between the ventral hippocampus and amygdala during renewal of fear
恐惧更新期间腹侧海马和杏仁核之间的相互作用
- 批准号:
8133814 - 财政年份:2010
- 资助金额:
$ 24.9万 - 项目类别:
Interactions between the ventral hippocampus and amygdala during renewal of fear
恐惧更新期间腹侧海马和杏仁核之间的相互作用
- 批准号:
7998303 - 财政年份:2010
- 资助金额:
$ 24.9万 - 项目类别:
相似国自然基金
时空序列驱动的神经形态视觉目标识别算法研究
- 批准号:61906126
- 批准年份:2019
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
本体驱动的地址数据空间语义建模与地址匹配方法
- 批准号:41901325
- 批准年份:2019
- 资助金额:22.0 万元
- 项目类别:青年科学基金项目
大容量固态硬盘地址映射表优化设计与访存优化研究
- 批准号:61802133
- 批准年份:2018
- 资助金额:23.0 万元
- 项目类别:青年科学基金项目
针对内存攻击对象的内存安全防御技术研究
- 批准号:61802432
- 批准年份:2018
- 资助金额:25.0 万元
- 项目类别:青年科学基金项目
IP地址驱动的多径路由及流量传输控制研究
- 批准号:61872252
- 批准年份:2018
- 资助金额:64.0 万元
- 项目类别:面上项目
相似海外基金
Novel application of pharmaceutical AMD3100 to reduce risk in opioid use disorder: investigations of a causal relationship between CXCR4 expression and addiction vulnerability
药物 AMD3100 降低阿片类药物使用障碍风险的新应用:CXCR4 表达与成瘾脆弱性之间因果关系的研究
- 批准号:
10678062 - 财政年份:2023
- 资助金额:
$ 24.9万 - 项目类别:
Rapid measurement of novel harm reduction housing on HIV risk, treatment uptake, drug use and supply
快速测量新型减害住房对艾滋病毒风险、治疗接受情况、毒品使用和供应的影响
- 批准号:
10701309 - 财政年份:2023
- 资助金额:
$ 24.9万 - 项目类别:
Using in-vivo Real-time Biosensor to Evaluate Prodrugs Designed to Prolong Therapeutic Effects for Smoking Cessation.
使用体内实时生物传感器评估旨在延长戒烟治疗效果的前药。
- 批准号:
10546293 - 财政年份:2023
- 资助金额:
$ 24.9万 - 项目类别:
Circuit control of motivation to take and seek alcohol
饮酒和寻求酒精动机的电路控制
- 批准号:
10753712 - 财政年份:2023
- 资助金额:
$ 24.9万 - 项目类别:
The impact of early life opioid exposure on the molecular and functional trajectories of septal cell types
生命早期阿片类药物暴露对隔膜细胞类型分子和功能轨迹的影响
- 批准号:
10775154 - 财政年份:2023
- 资助金额:
$ 24.9万 - 项目类别: